AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32554067 — intervention group
Group type: COMPARATOR
Intervention: Propofol, fentanyl, and midazolam
Number of subjects: 141
Study 32543980 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional cryotherapy (ILC)
Number of subjects: 130
Study 32543980 — intervention group
Group type: COMPARATOR
Intervention: Cryotherapy spray (Cryo‐sp)
Number of subjects: 130
Study 32267071 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal insulin analog (BI)
Number of subjects: 814
Study 32267071 — intervention group
Group type: EXPERIMENTAL
Intervention: Mid-mixture insulin analog (MMI)
Number of subjects: 814
Study 32267071 — intervention group
Group type: COMPARATOR
Intervention: Both BI and MMI
Number of subjects: 814
Study 34255891 — intervention group
Group type: EXPERIMENTAL
Intervention: Apremilast 30 mg BID
Number of subjects: 1062
Study 32146698 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific mobility and falls prevention class
Number of subjects: 780
Study 32146698 — intervention group
Group type: EXPERIMENTAL
Intervention: DXA scan
Number of subjects: 780
Study 34348792 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-load resistance training combined with blood flow restriction (LRT-BFR)
Number of subjects: 51
Study 34348792 — intervention group
Group type: EXPERIMENTAL
Intervention: High-load resistance training (CRT)
Number of subjects: 51
Study 34348792 — intervention group
Group type: COMPARATOR
Intervention: No-strength training control
Number of subjects: 51
Study 33086512 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritionally complete, high-protein diet for 6 months
Number of subjects: 74
Study 34051428 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaxseed oil (4 g ALA/day)
Number of subjects: 24
Study 34051428 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (4 g DHA + 0.8 g EPA/day)
Number of subjects: 24
Study 35857936 — intervention group
Group type: EXPERIMENTAL
Intervention: Billroth I anastomosis
Number of subjects: 108
Study 35857936 — intervention group
Group type: COMPARATOR
Intervention: Billroth II combined with Braun anastomosis
Number of subjects: 108
Study 35857936 — intervention group
Group type: COMPARATOR
Intervention: Roux-en-Y anastomosis
Number of subjects: 108
Study 33531271 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound imaging (US) for echo-intensity measures
Number of subjects: 25
Study 33531271 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound imaging (US) for morphological measures
Number of subjects: 25
Study 33531271 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound imaging (US) for cross-sectional area (CSA) and perimeter measures
Number of subjects: 25
Study 33531271 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound imaging (US)
Number of subjects: 25
Study 36183308 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-inflammatory accompanied by a low-calorie diet
Number of subjects: 60
Study 33973917 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% povidone-iodine
Number of subjects: 100
Study 33973917 — intervention group
Group type: COMPARATOR
Intervention: Artificial tears
Number of subjects: 100
Study 35471192 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise + nutrient-dense energy restriction of 500 kcal/d group
Number of subjects: 163
Study 35471192 — intervention group
Group type: COMPARATOR
Intervention: Exercise + nutrient-dense weight maintenance group
Number of subjects: 163
Study 35471192 — intervention group
Group type: COMPARATOR
Intervention: Exercise only group
Number of subjects: 163
Study 35313751 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training program
Number of subjects: 257
Study 35313751 — intervention group
Group type: COMPARATOR
Intervention: Usual rehabilitation care guideline recommended
Number of subjects: 257
Study 32138809 — intervention group
Group type: EXPERIMENTAL
Intervention: Uterine preservation
Number of subjects: 771
Study 32138809 — intervention group
Group type: COMPARATOR
Intervention: Vaginal hysterectomy
Number of subjects: 771
Study 32138809 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal procedure
Number of subjects: 771
Study 32138809 — intervention group
Group type: COMPARATOR
Intervention: Vaginal procedure
Number of subjects: 771
Study 35320135 — intervention group
Group type: EXPERIMENTAL
Intervention: EMG-controlled games training (unilateral or bilateral)
Number of subjects: 20
Study 35320135 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 20
Study 33685838 — intervention group
Group type: EXPERIMENTAL
Intervention: MDT (stereotactic ablative body radiotherapy [SABR] or surgery) without HT
Number of subjects: 72
Study 33685838 — intervention group
Group type: EXPERIMENTAL
Intervention: MDT (surgery)
Number of subjects: 72
Study 33685838 — intervention group
Group type: EXPERIMENTAL
Intervention: MDT (SABR)
Number of subjects: 72
Study 33685838 — intervention group
Group type: EXPERIMENTAL
Intervention: MDT
Number of subjects: 72
Study 35623756 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes Community Exercise and Education Programme (DCEP) - twice weekly sessions of exercise and education over 12 weeks, followed by ongoing exercise classes.
Number of subjects: 31
Study 32620379 — intervention group
Group type: EXPERIMENTAL
Intervention: Bee-Humming Breathing (BHB) exercise
Number of subjects: 70
Study 32620379 — intervention group
Group type: COMPARATOR
Intervention: Placebo slow breathing exercise
Number of subjects: 70
Study 35907490 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard daily dosing of vitamin D
Number of subjects: 0
Study 35907490 — intervention group
Group type: EXPERIMENTAL
Intervention: Loading doses followed by standard daily dosing of vitamin D
Number of subjects: 0
Study 34423510 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination group treated with 30% GA peel at 2 weekly intervals with 5% TXA solution applied twice daily
Number of subjects: 60
Study 34423510 — intervention group
Group type: COMPARATOR
Intervention: Control group treated with only 30% GA peel every 2 weeks for 12 weeks
Number of subjects: 60
Study 34423510 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study 32304676 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% sugar tax
Number of subjects: 3584
Study 32304676 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiered sugar tax
Number of subjects: 3584
Study 32304676 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple traffic light FOP label
Number of subjects: 3584
Study 32304676 — intervention group
Group type: EXPERIMENTAL
Intervention: Health star rating FOP label
Number of subjects: 3584
Study 32304676 — intervention group
Group type: COMPARATOR
Intervention: No sugar tax
Number of subjects: 3584
Study 32304676 — intervention group
Group type: COMPARATOR
Intervention: No FOP label
Number of subjects: 3584
Study 32627621 — intervention group
Group type: EXPERIMENTAL
Intervention: Graphic card
Number of subjects: 150
Study 32627621 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational video
Number of subjects: 150
Study 32627621 — intervention group
Group type: COMPARATOR
Intervention: Routine prenatal counseling
Number of subjects: 150
Study 34941608 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-RIR (3 repetitions in reserve)
Number of subjects: 14
Study 34941608 — intervention group
Group type: COMPARATOR
Intervention: 0-RIR (0 repetitions in reserve)
Number of subjects: 14
Study 34941608 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-RIR
Number of subjects: 14
Study 34941608 — intervention group
Group type: COMPARATOR
Intervention: 0-RIR
Number of subjects: 14
Study 34941608 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-RIR and 0-RIR
Number of subjects: 14
Study 33385308 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training program (AET) for 3 months
Number of subjects: 16
Study 33385308 — intervention group
Group type: COMPARATOR
Intervention: Stretching and toning program (SAT)
Number of subjects: 16
Study 33385308 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training program (AET)
Number of subjects: 16
Study 33385308 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training program (AET) and Stretching and toning program (SAT)
Number of subjects: 16
Study 35172878 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment holiday (TH) group: belimumab 10 mg/kg IV discontinued for 24 weeks, then restarted 10 mg/kg IV every 4 weeks for 28 weeks
Number of subjects: 41
Study 35172878 — intervention group
Group type: COMPARATOR
Intervention: Treatment continuation (TC) group: continued on belimumab 10 mg/kg IV plus standard therapy every 4 weeks for 52 weeks
Number of subjects: 41
Study 35172878 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term discontinuation (LTD) group: permanently withdrawn from further belimumab treatment
Number of subjects: 41
Study 34188449 — intervention group
Group type: EXPERIMENTAL
Intervention: Neratinib plus capecitabine
Number of subjects: 0
Study 34188449 — intervention group
Group type: COMPARATOR
Intervention: Lapatinib plus capecitabine
Number of subjects: 0
Study 32215272 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined resistance-aerobic training for 3 sessions during eight weeks
Number of subjects: 24
Study 34517991 — intervention group
Group type: EXPERIMENTAL
Intervention: Overdentures
Number of subjects: 0
Study 34517991 — intervention group
Group type: COMPARATOR
Intervention: Conventional complete dentures
Number of subjects: 0
Study 34322921 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandala drawing sessions (2 sessions of 1-2 hours each)
Number of subjects: 60
Study 34322921 — intervention group
Group type: COMPARATOR
Intervention: Routine care only
Number of subjects: 60
Study 32622795 — intervention group
Group type: EXPERIMENTAL
Intervention: OHT frailty screening tool
Number of subjects: 36790
Study 33411567 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based asthma self-management program (3 sessions over 2 months)
Number of subjects: 74
Study 33411567 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based asthma self-management program
Number of subjects: 74
Study 33411567 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 74
Study 32385825 — intervention group
Group type: EXPERIMENTAL
Intervention: NDD donors
Number of subjects: 622
Study 32385825 — intervention group
Group type: EXPERIMENTAL
Intervention: DCD donors
Number of subjects: 622
Study 32385825 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive procedures
Number of subjects: 622
Study 32385825 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall cohort
Number of subjects: 622
Study 35066982 — intervention group
Group type: EXPERIMENTAL
Intervention: EGF-containing cream
Number of subjects: 30
Study 35066982 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 33107666 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) - 10 weekly telephone sessions
Number of subjects: 500
Study 33107666 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga - 20 biweekly group yoga classes
Number of subjects: 500
Study 33107666 — intervention group
Group type: COMPARATOR
Intervention: Preference effect (average effect for those who received their preferred intervention)
Number of subjects: 500
Study 33107666 — intervention group
Group type: COMPARATOR
Intervention: Selection effect (effect on outcomes of self‐selection to a specific intervention)
Number of subjects: 500
Study 33184771 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental diffusion essential oil therapy (EOT) combined with psychotropic drug therapy (group A)
Number of subjects: 32
Study 33184771 — intervention group
Group type: COMPARATOR
Intervention: Psychotropic drug therapy alone (group B)
Number of subjects: 32
Study 36308124 — intervention group
Group type: EXPERIMENTAL
Intervention: Phacoemulsification
Number of subjects: 152
Study 36308124 — intervention group
Group type: COMPARATOR
Intervention: Manual Small-Incision Cataract Surgery (MSICS)
Number of subjects: 152
Study 36308124 — intervention group
Group type: EXPERIMENTAL
Intervention: Both MSICS and Phacoemulsification
Number of subjects: 152
Study 33075131 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational Adaptation (OA) training program
Number of subjects: 28
Study 33075131 — intervention group
Group type: COMPARATOR
Intervention: Skills-based (SB) training program
Number of subjects: 28
Study 32590969 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-based clubs with an empowerment curriculum
Number of subjects: 33
Study 35705204 — intervention group
Group type: EXPERIMENTAL
Intervention: ILF‐NF + TAU
Number of subjects: 93
Study 35705204 — intervention group
Group type: COMPARATOR
Intervention: TAU
Number of subjects: 93
Study 35011787 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-delivered, self-help comprehensive behavioral intervention for tics (ICBIT)
Number of subjects: 38
Study 35011787 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 38
Study 33034157 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai chi exercise intervention
Number of subjects: 100
Study 33034157 — intervention group
Group type: COMPARATOR
Intervention: Health education control
Number of subjects: 100
Study 33034157 — intervention group
Group type: EXPERIMENTAL
Intervention: All participants (controlling for intervention group)
Number of subjects: 100
Study 32989492 — intervention group
Group type: EXPERIMENTAL
Intervention: Transoral microdebrider (TOMD)
Number of subjects: 63
Study 32989492 — intervention group
Group type: COMPARATOR
Intervention: Transnasal microdebrider (TNMD)
Number of subjects: 63
Study 32180294 — intervention group
Group type: EXPERIMENTAL
Intervention: Turmeric extract, black pepper, and ginger
Number of subjects: 60
Study 32180294 — intervention group
Group type: COMPARATOR
Intervention: Naproxen
Number of subjects: 60
Study 34420543 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention based on Pender's HPM (nine 4-h training sessions and consulting support via phone contact and social media group)
Number of subjects: 202
Study 32014293 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated intimidation scenario
Number of subjects: 119
Study 32014293 — intervention group
Group type: EXPERIMENTAL
Intervention: Video of intimidation events
Number of subjects: 119
Study 32014293 — intervention group
Group type: COMPARATOR
Intervention: Control group (standardized lecture only)
Number of subjects: 119
Study 35065738 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic Balloon Dilation (EBD)
Number of subjects: 80
Study 35065738 — intervention group
Group type: COMPARATOR
Intervention: Fully Covered Self-Expandable Metal Stents (FCSEMS)
Number of subjects: 80
Study 35065738 — intervention group
Group type: EXPERIMENTAL
Intervention: Both EBD and FCSEMS
Number of subjects: 80
Study 34688944 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD1222 (ChAdOx1 nCoV-19) vaccine
Number of subjects: 256
Study 34688944 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 256
Study 33401984 — intervention group
Group type: EXPERIMENTAL
Intervention: SMOF Lipid 20% infusion
Number of subjects: 40
Study 33401984 — intervention group
Group type: COMPARATOR
Intervention: Standard supportive treatment
Number of subjects: 40
Study 33755235 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-weekly selinexor, bortezomib, and low-dose dexamethasone (XVd)
Number of subjects: 0
Study 33755235 — intervention group
Group type: COMPARATOR
Intervention: Standard twice-weekly bortezomib and moderate-dose dexamethasone (Vd)
Number of subjects: 0
Study 33152284 — intervention group
Group type: EXPERIMENTAL
Intervention: POAI (letrozole 2.5 mg per day or anastrozole 1 mg per day for 14 days)
Number of subjects: 4480
Study 33152284 — intervention group
Group type: COMPARATOR
Intervention: Control (no POAI)
Number of subjects: 4480
Study 33152284 — intervention group
Group type: EXPERIMENTAL
Intervention: POAI (in HER2-negative subpopulation)
Number of subjects: 4480
Study 33152284 — intervention group
Group type: EXPERIMENTAL
Intervention: POAI (in HER2-positive subpopulation)
Number of subjects: 4480
Study 33152284 — intervention group
Group type: EXPERIMENTAL
Intervention: POAI
Number of subjects: 4480
Study 33215681 — intervention group
Group type: EXPERIMENTAL
Intervention: Male soldiers carrying loads of 15, 35, and 55 kg
Number of subjects: 16
Study 33215681 — intervention group
Group type: EXPERIMENTAL
Intervention: Female soldiers carrying loads of 15, 35, and 55 kg
Number of subjects: 16
Study 33215681 — intervention group
Group type: EXPERIMENTAL
Intervention: Both male and female soldiers carrying loads of 15, 35, and 55 kg
Number of subjects: 16
Study 33215681 — intervention group
Group type: COMPARATOR
Intervention: Unloaded (BM) condition for both male and female soldiers
Number of subjects: 16
Study 33168953 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic predictors of educational attainment and intelligence test performance
Number of subjects: 46846
Study 36201969 — intervention group
Group type: EXPERIMENTAL
Intervention: Brisk-walking/jogging for 30 min, 2 sessions separated by 24 hours
Number of subjects: 12
Study 36201969 — intervention group
Group type: COMPARATOR
Intervention: Sedentary activities for 30 min
Number of subjects: 12
Study 33080002 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 3924
Study 33080002 — intervention group
Group type: COMPARATOR
Intervention: Control (non-tocilizumab treatment)
Number of subjects: 3924
Study 32332209 — intervention group
Group type: EXPERIMENTAL
Intervention: nabiximols
Number of subjects: 0
Study 32332209 — intervention group
Group type: EXPERIMENTAL
Intervention: cannabis
Number of subjects: 0
Study 36173670 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting mimicking diet
Number of subjects: 62
Study 36173670 — intervention group
Group type: COMPARATOR
Intervention: Foot reflexology
Number of subjects: 62
Study 32631801 — intervention group
Group type: EXPERIMENTAL
Intervention: Active learning education (n = 36)
Number of subjects: 95
Study 32631801 — intervention group
Group type: COMPARATOR
Intervention: Health education class (didactic) (n = 59)
Number of subjects: 95
Study 32718158 — intervention group
Group type: EXPERIMENTAL
Intervention: Online imaginal and psychoeducational interventions
Number of subjects: 0
Study 32718158 — intervention group
Group type: EXPERIMENTAL
Intervention: Imaginal contact with a person of color
Number of subjects: 0
Study 32718158 — intervention group
Group type: EXPERIMENTAL
Intervention: Learning and reflecting about racism and its impact on people of color
Number of subjects: 0
Study 32718158 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing awareness of White privilege and positionality
Number of subjects: 0
Study 32718158 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention components
Number of subjects: 0
Study 32718158 — intervention group
Group type: COMPARATOR
Intervention: Control components
Number of subjects: 0
Study 35678062 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Laser Therapy (HILT) plus Exercise Therapy (ET)
Number of subjects: 60
Study 35678062 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Intensity Pulsed Ultrasound (LIPUS) plus Exercise Therapy (ET)
Number of subjects: 60
Study 35678062 — intervention group
Group type: COMPARATOR
Intervention: Exercise Therapy (ET)
Number of subjects: 60
Study 32113972 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral plantar fascia manual pressure and traction technique
Number of subjects: 40
Study 32113972 — intervention group
Group type: COMPARATOR
Intervention: Tactile stimulation
Number of subjects: 40
Study 34622567 — intervention group
Group type: EXPERIMENTAL
Intervention: liraglutide (≤1.8 mg/d)
Number of subjects: 1991
Study 34622567 — intervention group
Group type: COMPARATOR
Intervention: oral antidiabetic drug (OAD)
Number of subjects: 1991
Study 34622567 — intervention group
Group type: EXPERIMENTAL
Intervention: liraglutide
Number of subjects: 1991
Study 34622567 — intervention group
Group type: COMPARATOR
Intervention: OAD
Number of subjects: 1991
Study 33726724 — intervention group
Group type: EXPERIMENTAL
Intervention: Complementary and alternative medicine (CAM) use
Number of subjects: 2001
Study 33726724 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural remedies
Number of subjects: 2001
Study 33726724 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help practices
Number of subjects: 2001
Study 33726724 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapies from CAM providers
Number of subjects: 2001
Study 33726724 — intervention group
Group type: EXPERIMENTAL
Intervention: CAM therapies from physicians
Number of subjects: 2001
Study 33726724 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean number of visits to herbalists
Number of subjects: 2001
Study 33726724 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean number of visits to healers
Number of subjects: 2001
Study 33726724 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived helpfulness of CAM
Number of subjects: 2001
Study 33412932 — intervention group
Group type: EXPERIMENTAL
Intervention: recall + Tetris
Number of subjects: 45
Study 33412932 — intervention group
Group type: EXPERIMENTAL
Intervention: recall + eye movements (EMs)
Number of subjects: 45
Study 33412932 — intervention group
Group type: COMPARATOR
Intervention: recall‐only
Number of subjects: 45
Study 32658817 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-focused therapy (FFT)
Number of subjects: 127
Study 32658817 — intervention group
Group type: COMPARATOR
Intervention: Enhanced care (EC)
Number of subjects: 127
Study 33100131 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA methylation at CpG sites (cg04816311, cg10254690, cg07660512)
Number of subjects: 961
Study 33100131 — intervention group
Group type: EXPERIMENTAL
Intervention: Seven identified CpGs associated with at least one trait (cg21134922, cg04816311, cg09155024, cg10254690, cg07660512, cg12661888, cg02264946)
Number of subjects: 961
Study 33100131 — intervention group
Group type: EXPERIMENTAL
Intervention: Three CpGs (cg04816311, cg10254690, cg07660512)
Number of subjects: 961
Study 33100131 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA methylation
Number of subjects: 961
Study 32991534 — intervention group
Group type: EXPERIMENTAL
Intervention: CG-CAHPS survey
Number of subjects: 105
Study 32991534 — intervention group
Group type: COMPARATOR
Intervention: Non-CAHPS surveys
Number of subjects: 105
Study 32991534 — intervention group
Group type: EXPERIMENTAL
Intervention: CAHPS measures
Number of subjects: 105
Study 34853187 — intervention group
Group type: EXPERIMENTAL
Intervention: Downhill running (DR: ‐15% slope)
Number of subjects: 8
Study 34853187 — intervention group
Group type: EXPERIMENTAL
Intervention: Level running (0%)
Number of subjects: 8